Home - Boston Life Sciences Times

LATEST ARTICLES

Technology

Sunoh.ai joins athenahealth Marketplace to expand access to AI-driven clinical documentation

Life Sciences Times - December 11, 20250

Biotech

Phare Bio and Basilea form partnership to develop AI-designed broad-spectrum antibiotic

Life Sciences Times - December 11, 20250

People on the Move

Suffolk hires Roger Moore to strengthen healthcare construction leadership in California

Life Sciences Times - December 11, 20250

Technology

Survey shows healthcare experts fear AI will accelerate online medical misinformation

Life Sciences Times - December 11, 20250

Technology

eClinical Solutions introduces AI agents to drive next-generation clinical data automation

Life Sciences Times - December 11, 20250

Biotech

Charles River extends incubator program with second global cohort

Life Sciences Times - December 11, 20250

Pharma

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

Life Sciences Times - December 11, 20250

Technology

Barking, Havering and Redbridge University Hospitals NHS Trust adopts Wolters Kluwer’s UpToDate Enterprise Edition to strengthen clinical decision-making

Life Sciences Times - December 10, 20250

Medtech

Vektor Medical receives FDA 510(k) clearance expanding vMap’s non-invasive cardiac mapping capabilities

Life Sciences Times - December 10, 20250

Biotech

Allonnia raises more than $20 million to accelerate deployment of materials biotechnology

Life Sciences Times - December 10, 20250

1...616263...831 Page 62 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Study Maps Microplastics Throughout the Body, Revealing Organ-Level Effects

FDA Advisory Panel Backs AstraZeneca’s TRUQAP Combination for PTEN-Deficient Prostate Cancer

POPULAR CATEGORY

ABOUT US

FOLLOW US